title: [Acute meningitis by Streptococcus agalactiae in a immunocompetent male].
authors.forename: Patricia
authors.initials: P
authors.lastname: Sanz-Rojas
authors.forename: Luis
authors.initials: L
authors.lastname: Cabeza-Osorio
authors.forename: Cecilia
authors.initials: C
authors.lastname: Hermosa
authors.forename: Regino
authors.initials: R
authors.lastname: Serrano-Heranz
mesh_terms: D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000008:administration & dosage / Q000627:therapeutic use; D003131:Combined Modality Therapy; D021821:Communicable Diseases, Emerging; D004359:Drug Therapy, Combination; D006801:Humans; D007121:Immunocompetence; D008297:Male; D016920:Meningitis, Bacterial / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D008875:Middle Aged; D010612:Pharyngitis / Q000150:complications / Q000188:drug therapy / Q000382:microbiology; D012121:Respiration, Artificial; D018805:Sepsis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology / Q000628:therapy; D013290:Streptococcal Infections / Q000134:cerebrospinal fluid / Q000188:drug therapy / Q000382:microbiology*; D013292:Streptococcus agalactiae / Q000302:isolation & purification*; D014640:Vancomycin / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D002316:Cardiotonic Agents; D014640:Vancomycin; D002443:Ceftriaxone